Funder: National Institutes of Health
Due Dates: September 16, 2025 (Letter of Intent) | October 17, 2025 (Full Application) | September 17, 2025 (Earliest Submission)
Funding Amounts: Up to $499,000 direct costs/year for up to 5 years; total program funding is $10M (FY25–26); up to 12 awards anticipated.
Summary: Supports multi-level intervention studies to address barriers in transitioning survivors of childhood and adolescent cancers from pediatric to adult care, aiming to improve long-term engagement and outcomes.
Key Information: Clinical trials are optional; multidisciplinary teams and focus on scalability/sustainability are required; foreign organizations are not eligible to apply, but foreign components are allowed.